首页> Neurobiology of disease> Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-β42 in an in vitro-model of inclusion-body myositis

Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-β42 in an in vitro-model of inclusion-body myositis

导出原文传递

翻译打印收藏纠错

作者： Nogalska,A. ^[1] ; D'Agostino,C. ; Engel,W.K. ; Askanas,V.

作者单位： USC Neuromuscular Center, Department of Neurology, University of Southern California Keck School of ^[1]

关键词 γ-Secretase Amyloid-β42 amyloid-β42-oligomers Autophagy Cathepsin B Cathepsin D Cultured human muscle fibers Lysosomal-activity Sodium phenylbutyrate Sporadic-inclusion body myositis

发布时间 2014-06-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Neurobiology of disease

2014年65卷

93-101页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Neurobiology of disease

2014年65卷

93-101页

检索历史清除

Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-β42 in an in vitro-model of inclusion-body myositis

Neurobiology of disease

相似文献

Neurobiology of disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-β42 in an in vitro-model of inclusion-body myositis

Neurobiology of disease

相似文献

Neurobiology of disease

相关期刊

检索历史清除